In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance Through Inhibition of Caspase-3–Mediated Apoptosis

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-16-1464
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

TARBP2-mediated Destabilization of Nanog Overcomes Sorafenib Resistance in Hepatocellular Carcinoma

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2019English

Hypoxia-Mediated Mitochondria Apoptosis Inhibition Induces Temozolomide Treatment Resistance Through miR-26a/Bad/Bax Axis

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2018English

Sorafenib in Hepatocellular Carcinoma

Clinical Medicine. Therapeutics
2009English

Growth Inhibition and Apoptosis Induction by (+)-Cyanidan-3-Ol in Hepatocellular Carcinoma

PLoS ONE
Multidisciplinary
2013English

Pterostilbene Inhibits Hepatocellular Carcinoma Through P53/Sod2/ROS-mediated Mitochondrial Apoptosis

Oncology Reports
MedicineCancer ResearchOncology
2016English

The Microenvironmental and Metabolic Aspects of Sorafenib Resistance in Hepatocellular Carcinoma

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2020English

Caspase-3-Mediated Cleavage of Rad9 During Apoptosis

Oncogene
Cancer ResearchGeneticsMolecular Biology
2003English

Suppression of P53 by Notch3 Is Mediated by Cyclin G1 and Sustained by MDM2 and miR-221 Axis in Hepatocellular Carcinoma

Oncotarget
Oncology
2014English

MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells Through Regulating the Tumor Metabolism

PLoS ONE
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy